Elevation of glutathione and related enzyme activities in high-grade and metastatic extremity soft tissue sarcoma

Annals of Surgical Oncology

Volumn 4, Issue 4, 1997, Pages 303-309

  Hochwald, Steven N ^a   Rose, D Michael ^a   Brennan, Murray F ^a   Burt, Michael E ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Chemoresistance; Glutathione; Metastases; Sarcoma

Indexed keywords

GAMMA GLUTAMYLTRANSFERASE; GLUTAMATE CYSTEINE LIGASE; GLUTATHIONE;

ADOLESCENT; ADULT; AGED; ARTICLE; CHEMISTRY; DRUG RESISTANCE; ENZYMOLOGY; FEMALE; HUMAN; LIMB; LUNG TUMOR; MALE; METABOLISM; METASTASIS; MIDDLE AGED; PATHOLOGY; SARCOMA; SOFT TISSUE TUMOR;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; DRUG RESISTANCE, NEOPLASM; EXTREMITIES; FEMALE; GAMMA-GLUTAMYLTRANSFERASE; GLUTAMATE-CYSTEINE LIGASE; GLUTATHIONE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; SARCOMA; SOFT TISSUE NEOPLASMS;

EID: 0031156696     PISSN: 10689265     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02303579     Document Type: Article

References (36)

1. Gadd MA, Casper ES, Woodruff JM, McCormack PM, Brennan MF. Development and treatment of pulmonary metastases in adult patients with extremity soft tissue sarcoma. Ann Surg 1993;218:705-12.
2. Bramwell V, Rouesse J, Steward W, et al. European experience of adjuvant chemotherapy for soft tissue sarcoma: interim report of a randomized trial of CYVADIC versus control. In: Ryan JR, Baker LH, eds. Recent concepts in sarcoma treatment. Dordrecht: Kluwer, 1988:23-49.
3. Chang AE, Kinsella T, Glatstein E, et al. Adjuvant chemotherapy for patients with high-grade soft-tissue sarcomas of the extremities. J Clin Oncol 1988;6:1491-500.
4. Blum RH, Edmonson JH. Investigations of ifosphamide (IF) for adult soft tissue sarcomas in ECOG. Eur J Cancer 1991;27:S350.
5. Schoenfeld D, Rosenbaum C, Horton J, et al. A comparison of adriamycin versus vincristine and adriamycin and cyclophosphamide for advanced sarcoma. Cancer 1982;50:2757-62.
6. Cordon-Cardo C, O'Brien JP, Boccia J, Casals D, Bertino JR, Melamed MR. Expression of the multidrug resistance gene product (P-glycoprotein) in human normal and tumor tissues. J Histochem Cytochem 1990;38:1277-87.
7. Li WW, Cordon-Cardo C, Chen Q, Jhanwar SC, Bertino JR. Establishment, characterization and drug sensitivity of four new human soft tissue sarcoma cell lines. Cancer (in press).
8. Goldstein LJ, Galski H, Fojo A, et al. Expression of multidrug resistance gene in human cancers. JNCI 1989;81:116-24.
9. Samuels BL, Murray JL, Cohen MB, et al. Increased glutathione peroxidase activity in a human sarcoma cell line with inherent doxorubicin resistance. Cancer Res 1991;51:521-7.
10. Meister A. Glutathione deficiency produced by inhibition of its synthesis, and its reversal; applications in research and therapy. Pharmacol Ther 1991;51:155-94.
11. Godwin AK, Meister A, O'Dwyer PJ, Huang CS, Hamilton TC, Anderson ME. High resistance to cisplatin in human ovarian cancer cell lines is associated with marked increase of glutathione synthesis. Proc Natl Acad Sci USA 1992;89: 3070-4.
12. Hajdu SI. Pathology of soft tissue tumors. Philadelphia: Lea & Febiger, 1979:1-55.
13. Hajdu SI, Shiu MH, Brennan MF. The role of the pathologist in the management of soft tissue sarcoma. World J Surg 1988;12:326-31.
14. Newton GL, Dorian R, Fahey RC. Analysis of biological thiols: derivatization with monobromobimane and separation by reverse phase HPLC. Anal Biochem 1981;117:383-7.
15. Anderson ME. Tissue glutathione. In: Greenwald A, ed. Handbook for oxygen radical research. Boca Raton: CRC Press, 1985:317-23.
16. Orlowski M, Meister A. Gamma-glutamyl-p-nitroanilide: a new convenient substrate for determination and study of l- and d-gamma-glutamyl transpeptidase activities. Biochim Biophys Acta 1963;73:679-81.
17. Nardi G, Cipollaro M, Loguercio C. Assay of gamma-glutamyl-cysteine synthetase and glutathione synthetase in erythrocytes by high-performance liquid chromatography with fluorimetric detection. J Chromatogr 1990;530:122-8.
18. Smith PK, Krohn RI, Hermanson GT, Mallia AK, Gartner FH. Measurement of protein using bicinchoninic acid. Anal Biochem 1985;150:76-85.
19. Gaynor JJ, Tan CC, Casper ES, et al. Refinement of clinicopathologic staging for localized soft tissue sarcoma of the extremity: a study of 423 adults. J Clin Oncol 1992;10: 1317-29.
20. Casper ES, Gaynor JJ, Harrison LB, Panicek DM, Hajdu SI, Brennan MF. Preoperative and postoperative adjuvant combination chemotherapy for adults with high grade soft tissue sarcoma. Cancer 1994;73:1644-51.
21. Brennan MF. Management of extremity soft-tissue sarcoma. Am J Surg 1989;158:71-8.
22. Tew KD. Glutathione-associated enzymes in anticancer drug resistance. Cancer Res 1994;54:4313-20.
23. Ozols RF, Louie KG, Plowman J, et al. Enhanced melphalan cytotoxicity in human ovarian cancer in vitro and in tumor-bearing nude mice by buthionine sulfoximine depletion of glutathione. Biochem Pharmacol 1987;36:147-53.
24. Hamilton T, O'Dwyer P, Young R, et al. Augmentation of adriamycin, melphalan, and cisplatin cytotoxicity in drug-resistant and -sensitive human ovarian ovarian carcinoma cell lines by buthionine sulfoximine mediated glutathione depletion. Biochem Pharmacol 1985;34:2583-6.
25. Kramer RA, Greene K, Ahmad S, Vistica DT. Chemosensitization of 1-phenylalanine mustard by the thiol-modulating agent buthionine sulfoximine. Cancer Res 1987;47:1593-7.
26. Meister A. Metabolism and function of glutathione. In: Dolphin D, Poulson R, Avramovic O, eds. Glutathione: part A. 1989:367-474.
27. Meister A, Anderson ME. Glutathione. Annu Rev Biochem 1983;52:711-60.
28. Gerber MA, Thung SN. Enzyme patterns in human hepatocellular carcinoma. Am J Pathol 1980;98:395-400.
29. Dempo K, Elliot KAC, Desmond W, Fishman WH. Demonstration of gamma-glutamyl transferase, alkaline phosphatase, CEA and HCG in human lung cancer. Oncodev Biol Med 1981;2:21-37.
30. Levine SE, Budwit DA, Michalopoulos GK, Georgiade GS, McCarthy KS. Gamma-glutamyl transpeptidase activity in benign and malignant human mammary epithelial lesions. Arch Pathol Lab Med 1983;107:423-7.
31. Bard S, Noel P, Chauvin F, Quash G. Gamma-glutamyl transpeptidase activity in human breast lesions: an unfavourable prognostic sign. Br J Cancer 1986;53:637-42.
32. Hanigan MH, Frierson HF, Brown JE, Lovell MA, Taylor PT. Human ovarian tumors express gamma-glutamyl transpeptidase. Cancer Res 1994;54:286-90.
33. Hanigan MH. Expression of gamma-glutamyl transpeptidase provides tumor cells with a selective growth advantage at physiologic concentrations of cyst(e)ine. Carcinogenesis 1995;16:181-5.
34. Hochwald SN, Harrison LE, Rose DM, Anderson ME, Burt ME. Gamma-glutamyl transpeptidase mediation of tumor glutathione utilization in vivo. JNCI 1996;88:193-7.
35. Meister A, Anderson ME, Hwang O. Intracellular cysteine and glutathione delivery systems. J Am Coll Nutr 1996;5:137-51.
36. Berger SJ, Gosky D, Zborowska E, Willson JKV, Berger NA. Selective enzymatic cycling assay for glutathione: measurements of glutathione content and its modulation by buthionine sulfoximine in vivo and in vitro in human colon cancer. Cancer Res 1994;54:4077-83.